Princeton, New Jersey 8540
David G. Glazer is a partner in Morgan Lewis's Business and Finance Practice and co-editor of the Morgan Lewis Deskbook for Emerging Growth Life Sciences Companies. Mr. Glazer's practice focuses on advising and representing technology companies, primarily in the life sciences, healthcare, and information technology industries. His clients range from early-stage biotechnology startups to global fortune 100 pharmaceutical companies, including medical device and specialty pharmaceutical companies, and his clients and deal experience extend throughout the United States, Europe, and Asia. Mr. Glazer regularly serves as outside counsel to these companies and counsels them in a variety of different transactions as well as strategic advice. His practice includes negotiation and structuring of licensing and other complex collaborations, corporate partnering arrangements, strategic alliances, mergers and acquisitions, spin-outs, supply and distribution arrangements, co-promotions and joint ventures. These transactions range from early-stage research collaborations to global alliances to develop and commercialize products. He has a solid understanding of the drug and device development and commercialization environment, expertise in early-stage research and development late stage product deals, and specific knowledge of issues in the life sciences industry such as indication, field, and territory splitting. Mr. Glazer works closely with his clients to understand their business and to structure and negotiate transactions to meet a client’s strategic objectives and to find practical solutions to a client’s most complex problems. He advises and counsels private equity, venture capital, and investment banking firms that focus on the life sciences industry.
Mr. Glazer is the author or co-author of a number of articles relating to the life sciences industry including: "Keep One Eye on the Collaboration, And the Other on Exit Events," New Jersey Law Journal, November 22, 2010; "Dividing the Intellectual Property Pie in the Life Sciences Industry," New Jersey Law Journal, April 14, 2011; and, "Changing the Environment for PharmaPharma-Biotech Collaborations, New Jersey LifeSciTech, Q4. In addition, he regularly guest lectures to law students and M.B.A. candidates with respect to licensing in the life sciences industry.
Mr. Glazer is admitted to practice in New Jersey and Pennsylvania and is a Certified Licensing Professional.
|Areas of Practice||1) Business & Finance, 2) Life Sciences, 3) Life Sciences Transactions, 4) Commercial Agreements, 5) Technology & Commercial Transactions, 6) Joint Ventures & Strategic Alliances, 7) Healthcare, 8) Life Sciences and Healthcare and 9) Mergers & Acquisitions|
|Law School||New York University School of Law|
|Education||Rutgers University (B.A., 1994)|
|Bar Member / Association||State Bar Of District of Columbia , State Bar Of Pennsylvania|
|Most recent firm||Morgan, Lewis & Bockius LLP|
Litigation Associate The candidate must have 0 to 7 years of experience. Excellent research and writing skills a must. Medical document review and trial preparation experience a plus. An activ...
Mid-sized insurance defense firm seeking a full time legal secretary with 5+ years experience. Must be familiar with insurance defense litigation, pleadings and discovery process of NJ State and ...
Senior Tax Counsel
Senior Tax Counsel Responsibilities: International tax planning. Assist in developing creative tax strategies to reduce Companies’ global effective tax rate and maximize cash flow opportunities; ...
|+ View more jobs|
Alan Singer is a partner in Morgan Lewis's Securities Practice. Mr. Singer advises companies with regard to a diverse range of corporate and securities matters.
Andrew Hamilton is a partner in Morgan Lewis's Business and Finance Practice. Mr. Hamilton practices in the areas of mergers and acquisitions, private equity and venture capital, securities law, and general corporate counseling.